Reduced Major Adverse Cardiovascular Events (MACE) with Interleukin-17 Inhibitors Compared to Methotrexate in Psoriasis Patients: A multi-center retrospective cohort analysis

Authors

Rahib K. Islam, LSU Health Sciences Center - New OrleansFollow
Alexander Maltese, University of Louisville, Kentucky
Kazi N. Islam, Central State University, Wilberforce, OH
Jashin J. Wu, University of Miami Miller School of Medicine, FL

Document Type

Article

Publication Date

3-13-2025

Publication Title

Journal of the American Academy of Dermatology

PubMed ID

40089023

Recommended Citation

Islam, Rahib K.; Maltese, Alexander; Islam, Kazi N.; and Wu, Jashin J., "Reduced Major Adverse Cardiovascular Events (MACE) with Interleukin-17 Inhibitors Compared to Methotrexate in Psoriasis Patients: A multi-center retrospective cohort analysis" (2025). School of Medicine Faculty Publications. 3719.
https://digitalscholar.lsuhsc.edu/som_facpubs/3719
10.1016/j.jaad.2025.03.014